Dana-Farber Cancer Institute, Brigham and Women’s Hospital’s Launch Profile, a Large-Scale Research Program to Scan Tumors for Mutations, Establish Extensive Genomic Database

BOSTON--(BUSINESS WIRE)--Committed to speeding the development of cancer treatments that target the genetic weaknesses in each patient’s tumor, Dana-Farber Cancer Institute and Brigham and Women’s Hospital have launched Profile, a major effort to scan tumor tissue from adult cancer patients for hundreds of gene mutations linked to cancer.